Sign up to save your podcasts
Or
Share Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients
At the 2024 AAHKS Annual Meeting, our Digital Health Committee Chair Shaun P. Patel, MD and Committee Member William B. Kurtz, MD had the pleasure of speaking with Saad Tarabichi, MD about his study presented at the meeting on “Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients.”
In this really study on a very common issue in the US – diabetes, Dr. Tarabichi uncovered that detecting diabetes is not as simple as we think it is. A study that initially starting with a FARE Grant by AAHKS recieved two years ago began looking into glycated albumin, a very standardized test. The study later consisted of a study with 1200 enrolled patients and Dr. Tarabichi predicting 90-day outcomes from these enrolled patients. Take a listen, I think the findings in this study will really surprise you.
Enjoy, and thanks for listening to AAHKS Amplified!
In This Episode:
William B. Kurtz, MD
Shaun P. Patel, MD
Saad Tarabichi, MD
The post Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients first appeared on AAHKS.
View all episodes
By American Association of Hip and Knee SurgeonsAt the 2024 AAHKS Annual Meeting, our Digital Health Committee Chair Shaun P. Patel, MD and Committee Member William B. Kurtz, MD had the pleasure of speaking with Saad Tarabichi, MD about his study presented at the meeting on “Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients.”
In this really study on a very common issue in the US – diabetes, Dr. Tarabichi uncovered that detecting diabetes is not as simple as we think it is. A study that initially starting with a FARE Grant by AAHKS recieved two years ago began looking into glycated albumin, a very standardized test. The study later consisted of a study with 1200 enrolled patients and Dr. Tarabichi predicting 90-day outcomes from these enrolled patients. Take a listen, I think the findings in this study will really surprise you.
Enjoy, and thanks for listening to AAHKS Amplified!
In This Episode:
William B. Kurtz, MD
Shaun P. Patel, MD
Saad Tarabichi, MD
The post Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients first appeared on AAHKS.